Fanconi Anemia, Complementation Group L (FANCL) (Middle Region) Peptide
FANCL
Reactivité: Humain
Hôte: Synthetic
BP, IHC, WB
N° du produit ABIN976692
Aperçu rapide pour Fanconi Anemia, Complementation Group L (FANCL) (Middle Region) Peptide (ABIN976692)
Antigène
FANCL
(Fanconi Anemia, Complementation Group L (FANCL))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-FANCL antibody (Catalog #: ARP56321_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- FANCL (Fanconi Anemia, Complementation Group L (FANCL))
-
Sujet
-
The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FAN
Alias Symbols: FAAP43, FLJ10335, PHF9, POG
Protein Interaction Partner: ACVR1,BMPR1B,C17orf70,GGN,HES1,TGFBR1,FANCA,FANCM,YDL160C-A,YOL086W-A
Protein Size: 380 -
Poids moléculaire
- 42 kDa
-
ID gène
- 55120
-
NCBI Accession
- NM_001114636, NP_001108108
-
UniProt
- Q9NW38
Antigène
-
Vous êtes ici:
